biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Post by ColwellCapIRon Dec 04, 2019 2:18pm

140 Views

Post# 30421893

5 Dec 19 (09:15 EST) Presentation Webcast (link/dial-in)

Webcast access via:
Internet: link
Dial-in: 1-800-319-4610 (within Canada / USA) or
+1-604-638-5340 (International Toll)
_____________________________________
Following the formal annual general meeting (“AGM”) proceedings, the Company will host a webcast presentation and conference call, currently scheduled for 09:15 am EST, Thursday, December 5, 2019. It is highly recommended to access the webcast over the Internet using the following link. A replay of the webcast (using the same link provided) will be available for one month following the conclusion of the event.

If dialing in by phone, dial 1-800-319-4610 (within Canada / USA) or +1-604-638-5340 (International Toll). Callers should dial-in 5-10 minutes prior to the scheduled start time and simply ask to join the call. A teleconference replay will be available for two weeks following the conclusion of the event and can be accessed by dialing 1-800-319-6413 (within Canada / USA) or +1-604-638-9010 (International Toll) and using the replay access code: 3903#.
_____________________________
Complete release: https://www.bioasis.us/bioasis-to-host-annual-general-meeting-webcast-on-december-5-2019/?utm_source=Bioasis+Technologies%2C+Inc.&utm_campaign=770dd1d57b-RSS+News+Email&utm_medium=email&utm_term=0_074d2aff60-770dd1d57b-27501445